Queen Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 18-04-2024
- Paid Up Capital ₹ 1.31 Cr
as on 18-04-2024
- Company Age 18 Year, 9 Months
- Last Filing with ROC 31 Mar 2010
About Queen Pharmaceuticals
- CIN/LLPIN
U51397TN2006PLC059303
- Company No.
059303
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 Mar 2006
- Date of AGM
25 Sep 2010
- Date of Balance Sheet
31 Mar 2010
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Queen Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saleem Haniffa  | Managing Director | 27-Mar-2006 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramamurthy Ayyavuthevar | Director | 17-Jan-2011 | Current |
| Veluchamy Sivakumar | Director | 27-Mar-2006 | Current |
| Malathi Ramamurthy | Director | 17-Jan-2011 | Current |
| Kamatchi Radha | Additional Director | 27-Feb-2009 | Current |
| Adam Sathick | Director | 27-Mar-2006 | Current |
| Kader Jegabber | Director | 11-Sep-2006 | Current |
Financial Performance of Queen Pharmaceuticals.
Enhance accessibility to Queen Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Queen Pharmaceuticals?
Unlock access to Queen Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Regenix Super Speciality Laboratories Private LimitedActive 13 years 7 monthsRamamurthy Ayyavuthevar and Malathi Ramamurthy are mutual person
Regenix Drugs LimitedActive 17 years 7 monthsRamamurthy Ayyavuthevar and Malathi Ramamurthy are mutual person
Regenix Biosciences LimitedActive 18 years 10 monthsRamamurthy Ayyavuthevar and Malathi Ramamurthy are mutual person
Karaikudi Medical Centre And Hospital LimitedActive 10 years 11 monthsSaleem Haniffa and Kamatchi Radha are mutual person
Prime Pharmaceuticals Private LimitedActive 29 years 3 monthsRamamurthy Ayyavuthevar is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Queen Pharmaceuticals?
Unlock and access historical data on people associated with Queen Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Queen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Queen Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
